Raghavan Preethi, Perez Cynthia A, Sorrentino Thomas A, Kading Jacqueline C, Finbloom Joel A, Desai Tejal A
University of California, Berkeley─University of California, San Francisco Graduate Program in Bioengineering, San Francisco, California 94158, United States.
Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California 94158, United States.
ACS Appl Mater Interfaces. 2025 Feb 12;17(6):8862-8874. doi: 10.1021/acsami.4c17324. Epub 2025 Jan 30.
Neutrophil extracellular traps (NETs) are networks of decondensed chromatin, histones, and antimicrobial proteins released by neutrophils in response to an infection. NET overproduction can cause an exacerbated hyperinflammatory response in a variety of diseases and can lead to host tissue damage without clearance of infection. Nanoparticle drug delivery is a promising avenue for creating materials that can both target NETs and deliver sustained amounts of NET-degrading drugs to alleviate hyperinflammation. Here, we study how particle physicochemical properties can influence NET interaction and leverage our findings to create NET-interfacing and NET-degrading particles. We fabricated a panel of particles of varying sizes (200 to 1000 nm) and charges (positive, neutral, negative) and found that positive charge is the main driver of NET-particle interaction, with smaller 200 nm positive particles having a 10-fold increase in binding compared to larger 1000 nm positive particles. Negative and neutral particles were mostly noninteracting, except for small negatively charged particles that exhibited very low levels of NET localization. Interaction strength of particles with NETs was quantified via shear flow assays and atomic force microscopy. This information was leveraged to create DNase-loaded particles that could adhere to NETs at varying degrees and therefore degrade NETs at different rates . Positively charged, 200 nm DNase-loaded particles showed the highest degree of interaction with NETs and therefore led to faster degradation compared with larger sizes, underscoring the importance of physicochemical design for NET-targeting drug delivery. Overall, this work provides fundamental knowledge of the drivers of particle-NET interaction and a basis for designing NET-targeting particles for various disease states.
中性粒细胞胞外诱捕网(NETs)是中性粒细胞在受到感染时释放的解聚染色质、组蛋白和抗菌蛋白网络。NETs过度产生可在多种疾病中导致加剧的过度炎症反应,并可在未清除感染的情况下导致宿主组织损伤。纳米颗粒药物递送是一种有前景的途径,可用于制造既能靶向NETs又能递送持续量的NET降解药物以减轻过度炎症的材料。在此,我们研究颗粒的物理化学性质如何影响与NETs的相互作用,并利用我们的发现来制造与NETs相互作用并降解NETs的颗粒。我们制备了一组不同大小(200至1000纳米)和电荷(正、中性、负)的颗粒,发现正电荷是NET-颗粒相互作用的主要驱动因素,与较大的1000纳米正颗粒相比,较小的200纳米正颗粒的结合增加了10倍。负电荷和中性颗粒大多不相互作用,除了带少量负电荷的颗粒表现出极低水平的NET定位。通过剪切流分析和原子力显微镜对颗粒与NETs的相互作用强度进行了量化。利用这些信息制造了负载脱氧核糖核酸酶(DNase)的颗粒,这些颗粒可以在不同程度上附着于NETs,因此可以以不同速率降解NETs。带正电荷的200纳米负载DNase的颗粒与NETs表现出最高程度的相互作用,因此与较大尺寸的颗粒相比导致更快的降解,突出了物理化学设计对NET靶向药物递送的重要性。总体而言,这项工作提供了颗粒-NET相互作用驱动因素的基础知识,并为设计针对各种疾病状态的NET靶向颗粒奠定了基础。